Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk, Danping Zheng, Oren Shibolet, et al.
EMBO Molecular Medicine (2018) Vol. 11, Iss. 2
Open Access | Times Cited: 448

Showing 1-25 of 448 citing articles:

Interaction between microbiota and immunity in health and disease
Danping Zheng, Timur Liwinski, Eran Elinav
Cell Research (2020) Vol. 30, Iss. 6, pp. 492-506
Open Access | Times Cited: 2805
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1153
The intestinal microbiota fuelling metabolic inflammation
Herbert Tilg, Niv Zmora, Timon E. Adolph, et al.
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 40-54
Closed Access | Times Cited: 806
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 787
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Robert F. Schwabe, Ira Tabas, Utpal B. Pajvani
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1913-1928
Open Access | Times Cited: 500
Phage therapy: From biological mechanisms to future directions
Steffanie A. Strathdee, Graham F. Hatfull, Vivek K. Mutalik, et al.
Cell (2023) Vol. 186, Iss. 1, pp. 17-31
Open Access | Times Cited: 395
Macrophage Polarization and Its Role in Liver Disease
Cheng Wang, Cheng Ma, Lihong Gong, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 376
Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential
Ran Guo, Lihua Chen, Chungen Xing, et al.
British Journal of Anaesthesia (2019) Vol. 123, Iss. 5, pp. 637-654
Open Access | Times Cited: 295
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Jiezhong Chen, Luis Vitetta
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5214-5214
Open Access | Times Cited: 247
Multidimensional Impact of Mediterranean Diet on IBD Patients
Fabio Chicco, Salvatore Magrì, Arianna Cingolani, et al.
Inflammatory Bowel Diseases (2020) Vol. 27, Iss. 1, pp. 1-9
Open Access | Times Cited: 199
Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
Anat Yaskolka Meir, Ehud Rinott, Gal Tsaban, et al.
Gut (2021) Vol. 70, Iss. 11, pp. 2085-2095
Open Access | Times Cited: 189
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Judith Aron‐Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1881-1898
Open Access | Times Cited: 188
Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management
D. Huang, Jason Behary, Amany Zekry
Internal Medicine Journal (2019) Vol. 50, Iss. 9, pp. 1038-1047
Closed Access | Times Cited: 182
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Tejeshwar Jain, Prateek Sharma, Abhi C. Are, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 132
Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease
Jing Cong, Ping Zhou, Ruiyan Zhang
Nutrients (2022) Vol. 14, Iss. 9, pp. 1977-1977
Open Access | Times Cited: 129
The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence
Huan Yi, Hengyang Peng, Xinyue Wu, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 121
Fructose and the Liver
Pablo Muriel, Pedro López‐Sánchez, Erika Ramos‐Tovar
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 112
The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
Rodrigo Zamignan Carpi, Sandra Maria Barbalho, Kátia Portero Sloan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8805-8805
Open Access | Times Cited: 88
Oral Exposure to Polystyrene Microplastics of Mice on a Normal or High-Fat Diet and Intestinal and Metabolic Outcomes
Takuro Okamura, Masahide Hamaguchi, Yuka Hasegawa, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 2
Open Access | Times Cited: 73
Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol
Ming Yang, Xiaoqiang Qi, Nan Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
Elena Kotsiliti, Valentina Leone, Svenja Schuehle, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 296-313
Open Access | Times Cited: 52
The crucial function of gut microbiota on gut-liver repair
Yamei Wang, Yan He, Qianqian Zheng, et al.
hLife (2025)
Open Access | Times Cited: 3
Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
Na Fei, Aurélia Bruneau, Xiaojun Zhang, et al.
mBio (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 137
Diet, nutrients and the microbiome
Wendy J. Dahl, Daniela Rivero‐Mendoza, Jason M. Lambert
Progress in molecular biology and translational science (2020), pp. 237-263
Closed Access | Times Cited: 129
Metabolic Targets in Nonalcoholic Fatty Liver Disease
William P. Esler, Kendra K. Bence
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 8, Iss. 2, pp. 247-267
Open Access | Times Cited: 124
Page 1 - Next Page

Scroll to top